Establishment of a Panel for services of preclinical contract research organizations (CROs)

Description

RSCI seeks to establish a panel of qualified preclinical contract research organisations (CROs) specialising in disease models to support our early-stage drug discovery and development projects. The chosen CROs will be added to the panel who can provide comprehensive preclinical research services, ensuring rigorous evaluation of potential therapeutic agents in various disease contexts. The successful CROs will be able to offer preclinical services in various areas, including but not limited to the following – applicants may apply if they have expertise in one or more of the following areas: 1. Disease Model Development and Validation; 2. Pharmacological Testing; 3. Efficacy Studies; 4. Safety and Toxicology Testing; 5. Mechanistic Studies; 6. Custom Research Services. The panel will be operational for a six year period and applications can be received at any time during this period, however there is an initial closing date of 31st July 2024.